The global IV equipment market size expected to reach USD 14.62 billion by 2026, at a CAGR of 6.2% during the forecast period 2021 to 2027. IV equipment are the medical devices used in the intravenous therapy to deliver the liquid substances into the body through the intravenous system. The IV equipment are used to administer the injections and infusions by using the syringes and infusion pumps. These equipment must be sterile before administering into the vein. Intravenous therapy is the fastest route to deliver the medications into the body because the medication directly enter into the circulation through intravenous route. Market players are actively involved in the development of newer IV equipment which is most convenient to the patient drug administration. Moreover, the rise in prevalence of chronic diseases that require long-term treatment, the rise in a number of surgical procedures, and rise in demand for ambulatory infusion pumps owing to rise in the home care market are anticipated to fuel the IV equipment market over the forecast years. Furthermore, acquisitions and mergers, collaborations, and product launchings are the strategies adopted by the market players for generating the revenue in IV equipment market. For instance, in April 2017, ICU Medical Inc. acquired Hospira infusion systems for expanding the product portfolio including IV equipment.